We are pleased to announce that we have been recognized as Firm of the Year in multiple categories by India Business Law Journal in IBLJ Indian Law Firm
The IPAB allowed an appeal and granted a patent to Pfizer for Tofacitinib and its salts (application 991/MUMNP/2003). an appeal and granted a patent to Pfizer for its
The IPAB allowed an appeal and granted a patent related to the pharmaceutical composition of coenzyme Q10 to the University of Miami. The application claims were directed to pharmaceutical composition
We are pleased to share that we have been ranked as Outstanding law firm in the field of Intellectual Property and as Recommended law firm in the field
Who’s Who Legal 2019 In their indomitable quest to unleash the power of intangibles and harness the untapped Intellectual Property (IP) potential through specialized IP services, our leaders
Neeti Wilson speaks on ‘Patents, Innovation and Access to New Pharmaceuticals’ at the National Conference on IPR in Health Sciences organised by Amity University. The two day conference,
Archana Shanker and Devinder Singh Rawat discuss the interaction between the healthcare and pharmaceutical industries in India, especially on aspects related to advertising, pricing and regulatory, prefaced on
Parties can apply for a compulsory licence in India on several grounds, including that the invention is not worked in the country. Neeti Wilson explores. 2015 marks a
Archana Shanker and Devinder Singh Rawat discuss the rise and regulation of biosimilar biologics in the Indian pharmaceutical market. Biologics are an important component of the pharmaceutical industry and
Archana Shanker and Vidisha Garg explore the protection of therapeutic substances used under folk medicine practices as ‘traditional knowledge’ by special provisions of the patent law. In October 2012,
